Dupilumab Biosimilar, Human IgG1 L234A L235A P329G (LALAPG) Fc Silent Mutant. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Human IgG1 N297A Mutant. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Dupilumab Biosimilar, Human IgG1. The research grade dupilumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Evolocumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade evolocumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available.
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Nimotuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Nimotuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only...
Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...
Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use...
